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Abstract
Background: Systems biology approaches offer novel insights into the development of chronic liver diseases.
Current genomic databases supporting systems biology analyses are mostly based on microarray data. Although
these data often cover genome wide expression, the validity of single microarray experiments remains
questionable. However, for systems biology approaches addressing the interactions of molecular networks
comprehensive but also highly validated data are necessary.
Results: We have therefore generated the first comprehensive database for published molecular associations in
human liver diseases. It is based on PubMed published abstracts and aimed to close the gap between genome
wide coverage of low validity from microarray data and individual highly validated data from PubMed. After an
initial text mining process, the extracted abstracts were all manually validated to confirm content and potential
genetic associations and may therefore be highly trusted. All data were stored in a publicly available database,
Library of Molecular Associations http://www.medicalgenomics.org/databases/loma/news, currently holding
approximately 1260 confirmed molecular associations for chronic liver diseases such as HCC, CCC, liver fibrosis,
NASH/fatty liver disease, AIH, PBC, and PSC. We furthermore transformed these data into a powerful resource for
molecular liver research by connecting them to multiple biomedical information resources.
Conclusion: Together, this database is the first available database providing a comprehensive view and analysis
options for published molecular associations on multiple liver diseases.
Background
The completely sequenced human genome has made it
possible for modern medicine to step into an era rich in
genetic information and high-throughput genomic ana-
lysis [1]. Large gene expression databases [2,3] and
advancing technologies in proteomics [4] provide rich
sources for systemic evaluations of the development of
chronic liver diseases.
These novel and readily available genetic resources
and analytical tools may be the key to unravel the mole-
cular basis of diverse chronic liver diseases as many of
these must be regarded to be complex multigenic dis-
eases. Moreover, since an efficient treatment for many
of these conditions and diseases is lacking, further
understanding of the genetic background of chronic
liver disease will be crucial in order to develop new
therapies aimed at selected targets [5-10].
At present, large genetic association studies for liver
diseases are mostly based on microarray data or SAGE
[11,12]. Some of these data have recently lead to the
identification of prognosticly relevant subgroups in HCC
suggesting that a large quantity of microarray data may
aid in the identification of biologically relevant biochem-
ical mechanisms [13-15]. However, most publicly avail-
able microarray data on chronic liver disease covers
only a few samples [3]. Although these microarrays face
several limitations, the data cover large expression pro-
files. Arguably, the biggest disadvantage is the need of
confirming single microarray data by means of molecu-
lar biology, e.g. Northern Blot or RT-PCR. Single micro-
array experiments have been demonstrated to lack
reliability with respect to validity of individual single
gene expression profiles [16]. Thus, more recent micro-
array experiments of single probe experiments include
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molecular biology. However, these experiments can be
time consuming and costly. To overcome these limita-
tions for systems biology approaches to chronic liver
disease, we created a novel resource for systems biology
analysis of chronic liver diseases by using PubMed pub-
lished molecular associations. As multiple molecular fac-
tor genes have already been investigated in association
these published studies provide a rich source of known
molecular associations.
Implementation
Data Acquisition
In order to establish this database, the complete
PubMed database, currently containing more than 17
million publications, has initially been searched by
means of MeSH terms and text mining semi-automated
searches [17].
Initially, for each individual disease all abstracts were
searched for the disease name or respective MeSH
terms providing alternative names or abbreviations
which may also be used in the literature to describe the
respective disease. In detail the used MeSH search
strings in PubMed used for searching disease associated
abstracts were:
1) “Hepatocellular” [MeSH] OR “hepatocellular car-
cinoma” OR “HCC” OR “hepatoma” OR “liver can-
cer” OR “primary liver cancer” OR “liver tumor” OR
“liver carcinoma” OR “primary liver cancer” OR
“hepatic tumor” for HCC
2) “biliary tract cancer” OR “gallbladder cancer” OR
“cholangiocellular carcinoma” OR cholangiocarci-
noma for CCC
3) “fibrosis” OR “fibroses” for liver fibrosis
4) “NASH” OR “NAFLD” OR “nonalcoholic steato-
hepatitis” OR “non-alcoholic steatohepatitis” OR
“nonalcoholic fatty liver disease” [MeSH] for NASH
5) “AIH” OR “hepatitis, autoimmune” [MeSH] OR
“autoimmune hepatitis” for AIH
6) “PBC” OR “primary biliary cirrhosis” [MeSH] OR
“biliary cirrhosis, primary”
7) “PSC” OR “sclerosing cholangitis” OR “cholangitis,
sclerosing” [MeSH] OR “primary sclerosing cholangi-
tis” for PSC
The abstracts identified to be associated with the par-
ticular diseases were then searched for human, mouse,
and rat gene names and alias gene names as provided
by the Human Genome Organization (HUGO, http://
www.hugo-international.org. Making use of the pattern
matching capabilities of the Perl programming language
http://www.perl.org, we used a pattern matching
approach to identify gene names in the previously
selected abstracts. E.g. if the gene to be searched was
p53, the abstract was searched for any combinations of
signs starting with the letter p followed by the numbers
5 and 3. This approach ensured a most flexible search
strategy.
Mouse and rat gene names were also searched as not
all authors of published abstracts went conform with
the HUGO nomenclature and some of them did use
murine gene names in (comparative) human studies.
By this approach we gathered a total of 101026
abstracts, potentially holding information on genetic
associations to chronic liver disease. In detail we identi-
fied 44548 abstracts suggesting genetic associations for
HCC, 13710 for CCC, 917 for AIH, 37173 for liver
fibrosis, 2022 for NASH, 1211 for PBC and 1445 for
PSC.
This strategy revealed all abstracts containing both the
disease name and a gene name. However, also this semi-
automated search provided a first approximation to
genetic associations to liver diseases, as in multiple
abstracts this genetic association could not be confirmed
by reading the full abstract. E.g. the abstract may read
that the gene XY is not related to disease Z, which
would have also been detected by the described search
strategy. Thus these automatically, by means of text
mining identified abstracts, were then all individually
read to confirm the suggested genetic association with
the particular disease. We thereby obtained a large num-
ber of manually confirmed genetic associations to liver
diseases.
Thereby, we finally identified 574 molecular associa-
tions for HCC, 150 molecular associations for liver
fibrosis, 310 molecular associations for CCC, and 82
molecular associations for NASH. Only a few genes
were identified to be related to the development of auto-
immune liver disease: 29 abstracts describing molecular
associations were found to be related to AIH, 56 to
PBC, and 60 to PSC. Overall, we were able to identify a
total of 1260 molecular associations for major chronic
liver diseases. As all these molecular associations were
manually confirmed by reading the individual full pub-
lished abstract, and thus these molecular associations
can be trusted to be highly reliable.
Data organization, Webinterface
The above described strategy of identifying potential
genetic associations with chronic liver diseases identified
1260 genetic associations for several diverse chronic
liver diseases. Initially the retrieved genetic associations
were stored locally in a postgreSQL database http://
www.postgresql.org. Subsequently, this database was
then made publicly accessible and searchable through a
webinterface (Figure 1) implemented in PHP http://de.
php.net. It may also be downloaded as a single text file.
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information repositories
Since one of the major goals in implementing this data-
base was to perform high throughput systems biology
analyses, the LOMA genetic associations had to be
linked to commonly used and established bioinformatics
databases and knowledge repositories.
Gene descriptions were assembled from the NCBI
Entrez database [17], chromosomal location and Ensembl
ID information [18]. Furthermore, data on gene signaling
and molecular pathway affiliation were collected from the
Kyoto Encyclopedia of Genes and Genomes (KEGG,
[19]). Finally, the Gene Ontology database was accessed
to identify cellular component, biological process and
molecular function information for each gene.
Results and Discussion
Database design and rationale
A wide variety of human diseases have been demon-
strated to be genetic (inherited). Genetic mutations and
a variable genetic background have been demonstrated
to significantly influence the development and course of
multiple diseases as well as the efficiency of treatment
with diverse drugs.
Over the past decades molecular mechanisms and
individual factors have been shown to be involved in the
development of liver diseases and it has become clear
that most liver diseases such as liver cancer, cholangio-
cellular carcinoma, liver fibrosis, NASH or autoimmune
liver diseases are complex systemic diseases. Thus they
must not only be investigated focussing on individual,
potentially key regulatory genes but also with respect to
underlying genetic clusters and networks [7,20-22].
However, to investigate these complex molecular inter-
actions, data resources providing a comprehensive col-
lection of all genes involved in the development of the
diseases are urgently needed. Microarray and SAGE
databases hold a vast amount of gene expression profiles
[2,3]. However, the validity of individual microarray data
Figure 1 LOMA data search interface. LOMA offers multiple search options. Searches may be performed by means of individual gene names,
NCBI Gene IDs, Ensembl Gene IDs, or disease names. Also more complex searches may be performed by selecting disease, gene symbol, a
genetic pathway from KEGG, or a gene ontology from the “explore genetic association” panel.
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RT-PCR, Northern-Blot, Western-Blot, RFLP, or even
DNA Sequencing. As the later molecular techniques
m a yh a v eah i g h e rv a l i d i t yt h e yh a v em o s t l yb e e np u b -
lished in individual publications, currently not available
for high throughput analysis. Furthermore extracting
and analyzing information on genetic associations in
liver diseases already published is extremely time con-
suming as the respective databases may only be searched
for individual publications. However, in total, these data
provide a rich source of genetic information.
To overcome these obstacles, we designed a publicly
available database for genetic associations with human
(liver) diseases, Library of Molecular Associations
(LOMA). Currently, this database holds 1260 molecular
associations for a total of seven liver diseases, HCC,
CCC, liver fibrosis, AIH, PBC and PSC. Most molecular
associations were identified to be associated with HCC,
595, followed by CCC and liver fibrosis, 310 and 150
database entries, respectively. 82 entries were associated
with the development of NASH. As expected and in
concordance with a currently missing clear association
of genetic networks with autoimmune liver diseases,
only few genes were reported to be associated with AIH,
PBC, or PSC. However, as some of these diseases, espe-
cially PBC, have been demonstrated an increased relative
risk of the disease in twins and first grade relatives, a
genetic basis of the disease must be suspected. Thus
further research into the genetic basis of the disease is
warranted to identify targets for therapeutic treatment
of the disease.
In contrast to other available genetic association data-
bases such as the Genetic Association Database [23], our
database contains all published genetic associations with
each specific diseases as our semi-automated search was
designed to completely capture all associations.
Database usage
The LOMA database provides multiple search options
to support complex genetic analyses. Firstly, LOMA
offers the option to search for individual genes and their
association with different liver diseases. This search may
be performed by means of a search for individual gene
names, NCBI Gene IDs [17], Ensembl Gene IDs [18], or
disease names. Also more complex searches may be per-
formed by selecting disease, gene symbol, a genetic
pathway from KEGG [19], or a gene ontology from the
“explore genetic association” panel, providing a highly
detailed search option (Figure 1).
After executing a search, the result page for these
searches offers the genetic associations to individual dis-
eases if present. Furthermore, the results page gives a
summary on gene name, associated disease, NCBI Gene
ID [17], Ensembl Gene ID [18], information on the
Figure 2 LOMA results page. The result page provides information on disease and individual information as well as summaries on NCBI Gene
ID, Ensembl Gene ID, the species in which the molecular association to the disease was published, and number of publications reporting the
molecular association ("high” stands for two or more publications). The details link provides linkage to a rich source of individual molecular
information as shown in figure 3.
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names, chromosomal location, the association documenting reference(s), gene ontology informations, and associated genetic pathways.
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was published (if the respective gene was found to be
associated with the disease in human, this category was
set to “human” as default). The validation mode column
gives a rough estimate, whether a genetic association
was only published in a single article (low) or if the
genetic association was documented in two or more
articles (Figure 2). Finally, more details on the specific
gene such as gene alias names, chromosomal location,
the association documenting reference(s), gene ontology
informations, and associated genetic pathways were pro-
vided in the “details” section (Figure 3).
For example, if one wants to know all molecular
associations with the Wnt signaling pathway that have
been published to play a role in HCC development,
this is now easily possible with our database. On the
search site under Explore molecular associations one
would select “HCC” from the “Molecular Associations”
column and “Wnt Signaling Pathway” from the KEGG
column. The executed search will then return a num-
ber of Wnt signaling associated genes and target genes,
APC, AXIN1, CTNNB1, MMP7, PRKCA, SMAD4,
TP53.
For these molecular associations further information is
linked especially in the details section of each gene.
With this information one could for example evaluate
the enrichment of the Wnt signaling pathway among all
CCC related molecular factors.
Linkage to common bioinformatics databases
A key issue in developing this database was to provide
the hepatologic community with a powerful but simulta-
n e o u s l yh i g h l yr e l i a b l ea n dcomprehensive database to
perform systems biology based high-throughput searches
and comparison of gene expression, our database was
linked to multiple other sources of genomic or genetic
information and gene expression information in particu-
lar. This rich embedding of our database into the cur-
rent scenery of bioinformatics repositories provides
valuable connections which may support advanced
search and evaluation strategies.
In detail, LOMA has been linked to the most com-
monly used bioinformatics databases, such as PubMed
[17], the European Bioinformatics Institute Website
Ensembl [18], the bioinformatics resource of the
National Center of Biotechnology Information Entrez
Gene [17], the Mouse Genome Informatics Website
(MGI, [24]), and the Gene Ontology database, holding
functional information on genes and proteins [25].
These links were selected as they may in addition sup-
port automated correlation with additional genomic
information such as multiple sequence information,
microarray expression data, conserved domains, as well
as information on a gene’s function.
Comparison to other genetic association databases
Our database has been evaluated against other public
databases such as Genetic Association database,
HuGENavigator, or OMIM. This evaluation was per-
formed using the molecular associations to CCC devel-
opment. Comparing our text mining strategy to a
manually searched sample set of 1000 randomly selected
CCC associated abstracts, we documented a sensitivity
of our approach of 98% and a false negative rate for
abstracts not selected by or text mining approach but
containing molecular associations to CCC of 2%.
For CCC development our database contained all
associations also listed by other databases with two
exceptions, MRP2/ABCC2 which was published only
recently and the miRNA370 which was missed by our
search strategy [26]. In contrast however, we provide a
significantly larger list of genetic associations to CCC
development of 310 molecular associations compared to
6, 19, and 39 in Genetic Association database, HuGEN-
avigator, or OMIM, respectively.
Conclusion
The Library of Molecular Associations (LOMA) was
designed as a comprehensive database of highly reliable
molecular associations conceived to close the gap
between high-throughput molecular data for automated
analysis and individual reliable experimental data by
molecular biology. Currently this database supports
information on molecular associations for several liver
diseases, HCC, CCC, liver fibrosis, NASH/fatty liver dis-
ease, AIH, PBC and PSC. In addition, the database was
extensively embedded into the currently available geno-
mics repositories supporting advanced searches and
cross analyses with other databases.
Together, this database is the first available database
providing a comprehensive view and analysis options for
published molecular associations on multiple liver
diseases.
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